메뉴 건너뛰기




Volumn 11, Issue 1, 2016, Pages 101-106

HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LEUPRORELIN; PIRARUBICIN; PROSTATE SPECIFIC ANTIGEN; ZOLEDRONIC ACID; ANTINEOPLASTIC AGENT; DOXORUBICIN; HYDROXYPROPYL METHACRYLATE; METHACRYLIC ACID DERIVATIVE;

EID: 84958753513     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-015-0379-4     Document Type: Article
Times cited : (80)

References (29)
  • 2
    • 84888784541 scopus 로고    scopus 로고
    • Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage
    • COI: 1:CAS:528:DC%2BC2cXhtVykt74%3D, PID: 24269967
    • Nakamura H, Etrych T, Chytil P et al (2014) Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage. J Control Release 174:81–87
    • (2014) J Control Release , vol.174 , pp. 81-87
    • Nakamura, H.1    Etrych, T.2    Chytil, P.3
  • 3
    • 84873268296 scopus 로고    scopus 로고
    • The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
    • COI: 1:CAS:528:DC%2BC38Xhs1CjsbnI, PID: 23088862
    • Maeda H, Nakamura H, Fang J (2013) The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev 65:71–79
    • (2013) Adv Drug Deliv Rev , vol.65 , pp. 71-79
    • Maeda, H.1    Nakamura, H.2    Fang, J.3
  • 4
    • 84860777658 scopus 로고    scopus 로고
    • Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting
    • COI: 1:CAS:528:DC%2BC38Xms12iurk%3D, PID: 22450535
    • Maeda H (2012) Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc Jpn Acad Ser B Phys Biol Sci 88:53–71
    • (2012) Proc Jpn Acad Ser B Phys Biol Sci , vol.88 , pp. 53-71
    • Maeda, H.1
  • 5
    • 84919460238 scopus 로고    scopus 로고
    • Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls
    • COI: 1:CAS:528:DC%2BC2cXitFahtbfO, PID: 25425260
    • Nakamura H, Fang J, Maeda H (2015) Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls. Expert Opin Drug Deliv 12:53–64
    • (2015) Expert Opin Drug Deliv , vol.12 , pp. 53-64
    • Nakamura, H.1    Fang, J.2    Maeda, H.3
  • 6
    • 48349107149 scopus 로고    scopus 로고
    • Tumor-targeted nanomedicines: principles and practice
    • COI: 1:CAS:528:DC%2BD1cXptFSntr0%3D, PID: 18648371
    • Lammers T, Hennink WE, Storm G (2008) Tumor-targeted nanomedicines: principles and practice. Br J Cancer 99:392–397
    • (2008) Br J Cancer , vol.99 , pp. 392-397
    • Lammers, T.1    Hennink, W.E.2    Storm, G.3
  • 7
    • 51449104513 scopus 로고    scopus 로고
    • Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
    • COI: 1:CAS:528:DC%2BD1cXhtV2jurrF, PID: 19238631
    • Lammers T, Subr V, Peschke P et al (2008) Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer 99:900–910
    • (2008) Br J Cancer , vol.99 , pp. 900-910
    • Lammers, T.1    Subr, V.2    Peschke, P.3
  • 8
    • 84925785111 scopus 로고    scopus 로고
    • Synthesis and therapeutic effect of styrene-maleic acid copolymer conjugated pirarubicin
    • COI: 1:CAS:528:DC%2BC2MXkvVOqtLw%3D, PID: 25529761
    • Tsukigawa K, Liao L, Nakamura H et al (2015) Synthesis and therapeutic effect of styrene-maleic acid copolymer conjugated pirarubicin. Cancer Sci 106:270–278
    • (2015) Cancer Sci , vol.106 , pp. 270-278
    • Tsukigawa, K.1    Liao, L.2    Nakamura, H.3
  • 9
    • 77954837315 scopus 로고    scopus 로고
    • In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: survival improvement and inhibition of liver metastases
    • COI: 1:CAS:528:DC%2BC3cXhtVCktbjM, PID: 20579075
    • Daruwalla J, Nikfarjam M, Greish K et al (2010) In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: survival improvement and inhibition of liver metastases. Cancer Sci 101:1866–1874
    • (2010) Cancer Sci , vol.101 , pp. 1866-1874
    • Daruwalla, J.1    Nikfarjam, M.2    Greish, K.3
  • 10
    • 54449095986 scopus 로고    scopus 로고
    • Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastases
    • COI: 1:CAS:528:DC%2BD1MXltFSrtbg%3D, PID: 18953175
    • Daruwalla J, Greish K, Malcontenti-Wilson C et al (2009) Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastases. J Vasc Res 46:218–228
    • (2009) J Vasc Res , vol.46 , pp. 218-228
    • Daruwalla, J.1    Greish, K.2    Malcontenti-Wilson, C.3
  • 11
    • 84938700372 scopus 로고    scopus 로고
    • SMA-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases
    • Daruwalla J, Greish K, Malcontenti-Wilson C, et al (2015) SMA-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases. Surgery 158(1):236–47
    • (2015) Surgery , vol.158 , Issue.1 , pp. 236-247
    • Daruwalla, J.1    Greish, K.2    Malcontenti-Wilson, C.3
  • 12
    • 80054695837 scopus 로고    scopus 로고
    • Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles
    • COI: 1:CAS:528:DC%2BC3MXhtlWmur%2FN, PID: 21600248
    • Nakamura H, Fang J, Gahininath B et al (2011) Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles. J Control Release 155:367–375
    • (2011) J Control Release , vol.155 , pp. 367-375
    • Nakamura, H.1    Fang, J.2    Gahininath, B.3
  • 13
    • 0038051355 scopus 로고    scopus 로고
    • Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells
    • COI: 1:CAS:528:DC%2BD3sXksFWms7c%3D, PID: 12679883
    • Nagai K, Nagasawa K, Ishimoto A et al (2003) Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells. Cancer Chemother Pharmacol 51:512–518
    • (2003) Cancer Chemother Pharmacol , vol.51 , pp. 512-518
    • Nagai, K.1    Nagasawa, K.2    Ishimoto, A.3
  • 14
    • 42749106212 scopus 로고    scopus 로고
    • Chemotherapy for hormone-refractory prostate cancer. Cochrane Database Syst Rev 18(4):CD005247
    • Shelley M, Harrison C, Coles B, et al (2006) Chemotherapy for hormone-refractory prostate cancer. Cochrane Database Syst Rev 18(4):CD005247. doi:10.1002/14651858.CD005247.pub2
    • (2006) doi:10.1002/14651858.CD005247.pub2
    • Shelley, M.1    Harrison, C.2    Coles, B.3
  • 15
    • 33747469939 scopus 로고    scopus 로고
    • Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care’s Genitourinary Cancer Disease Site Group
    • PID: 16670021
    • Winquist E, Waldron T, Berry S et al (2006) Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care’s Genitourinary Cancer Disease Site Group. BMC Cancer 6:112
    • (2006) BMC Cancer , vol.6 , pp. 112
    • Winquist, E.1    Waldron, T.2    Berry, S.3
  • 16
    • 0029062830 scopus 로고
    • Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study
    • COI: 1:STN:280:DyaK2MzosFOitA%3D%3D, PID: 7656906
    • Anderstrom C, Eddeland A, Folmerz P et al (1995) Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study. Eur Urol 27:301–305
    • (1995) Eur Urol , vol.27 , pp. 301-305
    • Anderstrom, C.1    Eddeland, A.2    Folmerz, P.3
  • 17
    • 0026515856 scopus 로고
    • Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil
    • COI: 1:STN:280:DyaK387nsVSksQ%3D%3D, PID: 1540881
    • Laurie JA, Hahn RG, Therneau TM et al (1992) Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer 69:1440–1444
    • (1992) Cancer , vol.69 , pp. 1440-1444
    • Laurie, J.A.1    Hahn, R.G.2    Therneau, T.M.3
  • 18
    • 0021343919 scopus 로고
    • Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group study
    • COI: 1:STN:280:DyaL2c7gs1agsg%3D%3D, PID: 6362815
    • Stephens RL, Vaughn C, Lane M et al (1984) Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group study. Cancer 53:406–410
    • (1984) Cancer , vol.53 , pp. 406-410
    • Stephens, R.L.1    Vaughn, C.2    Lane, M.3
  • 19
    • 4744337716 scopus 로고    scopus 로고
    • Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
    • COI: 1:CAS:528:DC%2BD2cXot1Kmu7c%3D, PID: 15470214
    • Petrylak DP, Tangen CM, Hussain MH et al (2004) Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351:1513–1520
    • (2004) N Engl J Med , vol.351 , pp. 1513-1520
    • Petrylak, D.P.1    Tangen, C.M.2    Hussain, M.H.3
  • 20
    • 38349167518 scopus 로고    scopus 로고
    • Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study
    • COI: 1:CAS:528:DC%2BD1cXitVWitLs%3D, PID: 18182665
    • Berthold DR, Pond GR, Soban F et al (2008) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol 26:242–245
    • (2008) J Clin Oncol , vol.26 , pp. 242-245
    • Berthold, D.R.1    Pond, G.R.2    Soban, F.3
  • 21
    • 84869496799 scopus 로고    scopus 로고
    • Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
    • COI: 1:CAS:528:DC%2BC38XnsFOquro%3D, PID: 22595146
    • Maeda H (2012) Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release 164:138–144
    • (2012) J Control Release , vol.164 , pp. 138-144
    • Maeda, H.1
  • 22
    • 70649088695 scopus 로고    scopus 로고
    • Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
    • COI: 1:CAS:528:DC%2BD1MXhsFOltrnE, PID: 19793083
    • Seki T, Fang J, Maeda H (2009) Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application. Cancer Sci 100:2426–2430
    • (2009) Cancer Sci , vol.100 , pp. 2426-2430
    • Seki, T.1    Fang, J.2    Maeda, H.3
  • 23
    • 84922674063 scopus 로고    scopus 로고
    • Hormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: a systematic review with meta-analyses
    • COI: 1:STN:280:DC%2BC2cblslGktQ%3D%3D
    • Schmidt-Hansen M, Hoskin P, Kirkbride P et al (2014) Hormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: a systematic review with meta-analyses. Clin Oncol (R Coll Radiol) 26:e21–e46. doi:10.1016/j.clon.2014.06.016
    • (2014) Clin Oncol (R Coll Radiol) , vol.26 , pp. 21-46
    • Schmidt-Hansen, M.1    Hoskin, P.2    Kirkbride, P.3
  • 24
    • 79952999153 scopus 로고    scopus 로고
    • The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature
    • PID: 21349950
    • van de Water TA, Bijl HP, Schilstra C et al (2011) The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. Oncologist 16:366–377
    • (2011) Oncologist , vol.16 , pp. 366-377
    • van de Water, T.A.1    Bijl, H.P.2    Schilstra, C.3
  • 25
    • 83955164302 scopus 로고    scopus 로고
    • Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysis
    • PID: 21470787
    • Coen JJ, Zietman AL, Rossi CJ et al (2012) Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysis. Int J Radiat Oncol Biol Phys 82:e25–e31
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , pp. 25-31
    • Coen, J.J.1    Zietman, A.L.2    Rossi, C.J.3
  • 26
    • 84940956193 scopus 로고    scopus 로고
    • Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
    • PID: 25579058
    • Maeda H (2015) Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev. doi:10.1016/j.addr.2015.01.002
    • (2015) Adv Drug Deliv Rev
    • Maeda, H.1
  • 27
    • 84977865921 scopus 로고    scopus 로고
    • Photodynamic therapy based on tumor-targeted polymer-conjugated zinc protoporphyrin and irradiation with xenon light
    • Fang J, Liao L, Yin H, et al (2015) Photodynamic therapy based on tumor-targeted polymer-conjugated zinc protoporphyrin and irradiation with xenon light. Future Science OA FSO4. http://www.future-science.com/doi/pdf/10.4155/fso.15.2.
    • (2015) Future Science OA FSO4
    • Fang, J.1    Liao, L.2    Yin, H.3
  • 28
    • 75749149269 scopus 로고    scopus 로고
    • HPMA copolymers: origins, early developments, present, and future
    • COI: 1:CAS:528:DC%2BC3cXhs1arsbg%3D, PID: 19919846
    • Kopecek J, Kopecková P (2010) HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev 62:122–149
    • (2010) Adv Drug Deliv Rev , vol.62 , pp. 122-149
    • Kopecek, J.1    Kopecková, P.2
  • 29
    • 75749144204 scopus 로고    scopus 로고
    • Structural and chemical aspects of HPMA copolymers as drug carriers
    • COI: 1:CAS:528:DC%2BC3cXhs1arsbk%3D, PID: 19931329
    • Ulbrich K, Subr V (2010) Structural and chemical aspects of HPMA copolymers as drug carriers. Adv Drug Deliv Rev 62:150–166
    • (2010) Adv Drug Deliv Rev , vol.62 , pp. 150-166
    • Ulbrich, K.1    Subr, V.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.